1. Home
  2. NWN vs NVCR Comparison

NWN vs NVCR Comparison

Compare NWN & NVCR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Northwest Natural Holding Company

NWN

Northwest Natural Holding Company

HOLD

Current Price

$50.83

Market Cap

2.1B

Sector

Utilities

ML Signal

HOLD

Logo NovoCure Limited

NVCR

NovoCure Limited

HOLD

Current Price

$15.43

Market Cap

2.0B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
NWN
NVCR
Founded
1859
2000
Country
United States
Switzerland
Employees
1619
N/A
Industry
Oil/Gas Transmission
Medical/Dental Instruments
Sector
Utilities
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
2.1B
2.0B
IPO Year
2018
2015

Fundamental Metrics

Financial Performance
Metric
NWN
NVCR
Price
$50.83
$15.43
Analyst Decision
Buy
Buy
Analyst Count
3
6
Target Price
$54.33
$28.08
AVG Volume (30 Days)
244.6K
1.5M
Earning Date
05-06-2026
04-30-2026
Dividend Yield
3.71%
N/A
EPS Growth
36.45
21.79
EPS
2.33
N/A
Revenue
$1,289,363,000.00
$655,353,000.00
Revenue This Year
$11.37
$7.72
Revenue Next Year
$4.46
$6.74
P/E Ratio
$21.67
N/A
Revenue Growth
11.83
8.28
52 Week Low
$39.29
$9.82
52 Week High
$55.99
$18.92

Technical Indicators

Market Signals
Indicator
NWN
NVCR
Relative Strength Index (RSI) 57.55 44.45
Support Level $48.32 $14.85
Resistance Level $53.92 $15.19
Average True Range (ATR) 1.14 0.87
MACD 0.27 -0.33
Stochastic Oscillator 78.30 34.89

Price Performance

Historical Comparison
NWN
NVCR

About NWN Northwest Natural Holding Company

Northwest Natural Holding Co is a public natural gas service supplier operating in the U.S. Pacific Northwest. Its subsidiary, NW Natural, operates through the natural gas distribution segment, which purchases and distributes natural gas through which operates in Oregon and southwest Washington. The company operates in three reportable business segments, which are NWN Gas Utility, SiEnergy, and NWN Water. The company generates maximum revenue from NWN Gas Utility segment. It also generates revenue from residential, commercial, and industrial customers, the majority of which are in Oregon. Residential and commercial customers account for the vast majority of profitability.

About NVCR NovoCure Limited

NovoCure Ltd is an oncology company with a proprietary platform technology in the United States. Its business involves the development, manufacture, and commercialization of Tumor Treating Fields (TTFields) devices, including Optune Gio and Optune Lua, for the treatment of solid tumor cancers. Its pipeline consists of Trident, Lunar-2, Panova-3, Metis, and other products and technologies for the treatment of Glioblastoma, Non-small cell lung cancer, and Pancreatic cancer. Geographically, the company derives the majority of its revenue from the United States and the rest from Germany, Japan, and other markets.

Share on Social Networks: